Kimberly‑Clark Launches $7 Billion Kenvue Note Exchange as Deal Progresses

Kimberly‑Clark Corporation (NASDAQ: KMB) has taken a significant step this week in advancing its planned acquisition of Kenvue by launching an exchange offer for up to $7 billion of Kenvue‑linked notes, according to multiple recent disclosures.

On September 28, 2026, the company filed a Form 8‑K and issued a press release detailing the commencement of exchange offers and consent solicitations related to Kenvue notes, signaling a move to streamline financing ahead of the deal’s closing. These filings were disclosed in regulatory documentation and company communications that day.

Further confirmation comes from a story published by MET Magazine on October 1, 2026, which also reports that Kimberly‑Clark is now offering the exchange as part of its preparations for the Kenvue acquisition. This step is aimed at restructuring debt associated with Kenvue to facilitate smoother integration upon deal close.

The exchange offer is a pivotal development in the $40 billion takeover of Kenvue, the consumer-health spinoff of Johnson & Johnson. In recent weeks, Kimberly‑Clark has also engaged with EU regulators, preparing asset-sale remedies to address antitrust concerns and seek approval for the acquisition.

Investors and market watchers should note that the launch of the debt exchange is a concrete, material step in deal execution—distinct from earlier filings or speculative reports. It reflects growing momentum toward transaction close, though regulatory approvals remain an ongoing process.

Significance for Investors

This move to restructure Kenvue’s debt exposure signals Kimberly‑Clark’s commitment to managing integration risks and balance‑sheet implications ahead of closing. It also marks a transition from negotiation to implementation phase in the acquisition process.

Market participants will likely monitor next steps, including regulatory approvals, execution of any required asset sales, and adjustments to Kimberly‑Clark’s capital structure as the exchange offers progress.

Price Context: As of October 2, 2026, Kimberly‑Clark’s stock is trading at $94.36, reflecting a 0.8% decline on that day. While the exchange offer is unlikely to affect day‑to‑day trading, it underscores the strategic financial maneuvering underway in relation to the broader Kenvue transaction.

Overall, the debt exchange offer represents a measured but material advancement toward the planned acquisition, offering investors a clear marker of deal progression while leaving regulatory outcomes and final closing timing open as key next milestones.